TrueBinding
Sandy T. has a long and varied work experience. Sandy began their career in 2000 as a QC Analyst at Chiron Corporation. Sandy then moved to Genentech in 2005, where they were a QA Product Technical Manager. In 2012, Sandy took a role as QA Manager at Corium International. Sandy then moved to Heron Therapeutics, Inc. in 2014, where they held various roles including QA Mgr, Sr QA Mgr, and Associate Dir, QA. In 2017, Sandy began working at The Janssen Pharmaceutical Companies of Johnson & Johnson as Director, Quality Systems and Compliance. Most recently, in 2019, they joined FORESEE PHARMACEUTICALS, INC. as Sr. Director and Head of QA. In 2021, Sandy took a new role as Sr. Director and Head of Quality at TrueBinding.
Sandy T. holds a Graduate Certificate in Regulatory Science from the University of Maryland School of Pharmacy, a Bachelor's degree in Cell and Molecular Biology from the University of California, Berkeley, and is a Certified Quality Auditor from the American Society for Quality (ASQ).
This person is not in any offices
TrueBinding
TrueBinding is researching and developing first-in-class monoclonal antibody drugs to treat tumors, fibrotic diseases, metabolic diseases, autoimmune diseases, and neurologic diseases.